Willemse MJ - Search Results

1

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.

Willemse MJ, Seriu T, Hettinger K, d'Aniello E, Hop WC, Panzer-Grümayer ER, Biondi A, Schrappe M, Kamps WA, Masera G, Gadner H, Riehm H, Bartram CR, van Dongen JJ. Willemse MJ, et al. Blood. 2002 Jun 15;99(12):4386-93. doi: 10.1182/blood.v99.12.4386. Blood. 2002. PMID: 12036866 Free article.

2

Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease.

Szczepański T, Willemse MJ, Brinkhof B, van Wering ER, van der Burg M, van Dongen JJ. Szczepański T, et al. Among authors: willemse mj. Blood. 2002 Apr 1;99(7):2315-23. doi: 10.1182/blood.v99.7.2315. Blood. 2002. PMID: 11895762 Free article.

3

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR.

van der Velden VH, Willemse MJ, van der Schoot CE, Hählen K, van Wering ER, van Dongen JJ. van der Velden VH, et al. Among authors: willemse mj. Leukemia. 2002 May;16(5):928-36. doi: 10.1038/sj.leu.2402475. Leukemia. 2002. PMID: 11986956

4

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.

van der Velden VH, Jacobs DC, Wijkhuijs AJ, Comans-Bitter WM, Willemse MJ, Hählen K, Kamps WA, van Wering ER, van Dongen JJ. van der Velden VH, et al. Among authors: willemse mj. Leukemia. 2002 Aug;16(8):1432-6. doi: 10.1038/sj.leu.2402636. Leukemia. 2002. PMID: 12145681

5

T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia refelct 'end-stage' recombinations: implications for minimal residual disease monitoring.

Szczepański T, Langerak AW, Willemse MJ, Wolvers-Tettero IL, van Wering ER, van Dongen JJ. Szczepański T, et al. Among authors: willemse mj. Leukemia. 2000 Jul;14(7):1208-14. doi: 10.1038/sj.leu.2401765. Leukemia. 2000. PMID: 10914544

6

Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease.

van Wering ER, van der Linden-Schrever BE, Szczepański T, Willemse MJ, Baars EA, van Wijngaarde-Schmitz HM, Kamps WA, van Dongen JJ. van Wering ER, et al. Among authors: willemse mj. Br J Haematol. 2000 Jul;110(1):139-46. doi: 10.1046/j.1365-2141.2000.02143.x. Br J Haematol. 2000. PMID: 10930991 Free article.

7

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.

Biondi A, Valsecchi MG, Seriu T, D'Aniello E, Willemse MJ, Fasching K, Pannunzio A, Gadner H, Schrappe M, Kamps WA, Bartram CR, van Dongen JJ, Panzer-Grümayer ER. Biondi A, et al. Among authors: willemse mj. Leukemia. 2000 Nov;14(11):1939-43. doi: 10.1038/sj.leu.2401922. Leukemia. 2000. PMID: 11069029

8

Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: proposal for an easy strategy.

Szczepański T, Willemse MJ, Kamps WA, van Wering ER, Langerak AW, van Dongen JJ. Szczepański T, et al. Among authors: willemse mj. Med Pediatr Oncol. 2001 Mar;36(3):352-8. doi: 10.1002/mpo.1085. Med Pediatr Oncol. 2001. PMID: 11241436

9

Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14.

Szczepański T, Willemse MJ, van Wering ER, van Weerden JF, Kamps WA, van Dongen JJ. Szczepański T, et al. Among authors: willemse mj. Leukemia. 2001 Sep;15(9):1415-23. doi: 10.1038/sj.leu.2402206. Leukemia. 2001. PMID: 11516102

10

Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.

Boeckx N, Willemse MJ, Szczepanski T, van der Velden VH, Langerak AW, Vandekerckhove P, van Dongen JJ. Boeckx N, et al. Among authors: willemse mj. Leukemia. 2002 Mar;16(3):368-75. doi: 10.1038/sj.leu.2402387. Leukemia. 2002. PMID: 11896540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters